The Role of Biomarkers in Clinical Trials for Alzheimer Disease-Reference-Cited by-同舟云学术

The Role of Biomarkers in Clinical Trials for Alzheimer Disease

Published:2006-01 Issue:1 Volume:20 Page:6-15
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Thal Leon J,Kantarci Kejal,Reiman Eric M,Klunk William E,Weiner Michael W,Zetterberg Henrik,Galasko Douglas,Praticò Domenico,Griffin Sue,Schenk Dale,Siemers Eric

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference93 articles.

1. Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer disease.;Matthews;Am J Geriatr Psychiatry,2003

2. Biological markers for therapeutic trials in Alzheimers disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimers disease.;Frank;Neurobiol Aging,2003

3. Changes in premorbid brain volume predict Alzheimers disease pathology.;Silbert;Neurology,2003

4. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.;Fox;Arch Neurol,2000

5. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimers disease treatment studies.;Alexander;Am J Psychiatry,2002

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miniaturized Head-Mount Doppler Optical Coherence Tomography Scope for Freely Moving Mouse;ACS Photonics;2024-08-06

2. SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia;Biomedicines;2024-06-04

3. Biomarkers as Endpoints in Clinical Trials for Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-05-14

4. Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial;Journal of Alzheimer's Disease;2024-04-30

5. Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04